The global vitamin
D testing market is expected to reach USD 1.1 billion by 2025,
according to a new report by Grand View Research, Inc. Global increase in
geriatric population as well as cases of chronic illnesses is likely to drive
the market during the forecast period.
Furthermore, increase in investment for development
and commercialization of various accurate, innovative, and easy-to-use tests by
various market players and governments is likely to drive the market growth.
For instance, in January 2017, Future Diagnostics and DIA source received a
grant of EUR 1.4 million from the European Commission to develop a unique
CE-marked assay that can measure the level of free vitamin D (25OHD) in the
body. In addition, this assay will assist in early recovery of patients
suffering from vitamin D deficiency by providing optimized treatment, offering
an opportunity to save treatment costs.
Vitamin D assay measures the level of vitamin D in two
forms. Hence, the market has been divided by two major types of tests, namely
25-Hydroxy Vitamin D test and 1, 25-Dihydroxy vitamin test.
The 5-hydroxy vitamin D tests or assay segment
dominated in 2016 due to its greater ability to identify bone malformations,
softness, weakness, and fractures in adults. Its domination is likely to
continue in the forecast period as well.
Browse full research report on Vitamin D Testing Market: https://www.grandviewresearch.com/industry-analysis/vitamin-d-testing-market
Further
Key Findings From the Report Suggest:
- Rising incidence of chronic illnesses and growing geriatric
population are expected to propel the growth of the market with a CAGR of
9.4% from 2017 to 2025
- 5-hydroxy vitamin D test segment accounted for the largest share
and is anticipated to witness strong growth during the forecast period.
This can be attributed to the availability of several commercial products,
ongoing research in the field, and the ability to accurately detect bone
malformations.
- Geographically, North America held the largest share in 2016. It is
expected to maintain its dominance during the forecast period due to
higher awareness about screening, higher healthcare expenditure as
compared to other developing countries, and local presence of market
players.
- The industry in Asia Pacific is projected to witness substantial
growth over the next decade owing to growing investments by several market
players in the region, growing healthcare expenditure, and recent
commercialization of tests in major markets, such as Japan and China
- Some of the key players are Abbott Laboratories; F. Hoffmann-La
Roche Ltd.; Hologic, Inc.; Siemens Corporation; Danaher Corporation; Quest
Diagnostics, Inc.; bioMérieux SA; and DiaSorin S.p.A.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/clinical-diagnostics
Grand
View Research has segmented the global vitamin D testing market on the basis of
type of test and region:
Type
of Test Outlook (Revenue, USD Million, 2014 - 2025)
- 25-Hydroxy
Vitamin D Tests
- 1,
25-Dihydroxy Vitamin D Test
Regional
Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia Pacific
- China
- Central &
South America
- Brazil
- Middle East
& Africa
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment